Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines.
Invest New Drugs
; 30(4): 1484-92, 2012 Aug.
Article
in En
| MEDLINE
| ID: mdl-21881917
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polyglutamic Acid
/
Thymidylate Synthase
/
Cell Cycle
/
Coumarins
/
Enzyme Inhibitors
/
Folic Acid Antagonists
/
Melanoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Invest New Drugs
Year:
2012
Type:
Article
Affiliation country:
Italy